Galectin Therapeutics Inc. (GALT) market cap

Market cap today
$293.47M

Galectin Therapeutics Inc. (GALT) has a market cap of $293.47M. At the end of fiscal 2025 (December 31, 2025) its market cap was $265.84M. That is 230.7% higher than the $80.38M of fiscal 2024. Today's figure is 10.4% above the fiscal 2025 year-end. Figures as of 18 Nov 2026, 12:05 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Market cap today
$293.47M
Market cap, fiscal 2025
$265.84M
Change on fiscal 2024
+230.7%
Growth, 5 years
+15.8% a year
Highest on record
$265.84Mfiscal 2025
Lowest on record
$67.11Mfiscal 2022
Fiscal years on record
62020–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

Galectin Therapeutics Inc. market cap, in more detail

Over the five fiscal years to 2025 the market cap grew at a compound 15.8% a year. Across the 6 fiscal year-ends on record (2020–2025), the highest was $265.84M in fiscal 2025 and the lowest $67.11M in fiscal 2022.

History · 6 fiscal years

Market cap at each fiscal year-end

The last point is today's figure; the others are fiscal year-ends.

Galectin Therapeutics Inc. market cap, year by year

Galectin Therapeutics Inc. (GALT) market cap by fiscal year
Fiscal yearMarket capChangeYear endedShare price at year-endDiluted shares
Today$293.47M—$2.91—
2025$265.84M 230.7% up$4.1663.90M
2024$80.38M 19.5% down$1.2962.31M
2023$99.86M 48.8% up$1.6660.16M
2022$67.11M 44.6% down$1.1359.39M
2021$121.15M 5.2% down$2.0758.53M
2020$127.74M—$2.2457.03M
2019——$2.86—
2018——$3.43—
2017——$3.34—
2016——$0.98—
2015——$1.64—
2014——$3.47—
2013——$8.08—
2012——$2.05—
2011——$5.76—
2010——$5.40—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Market cap is the share price multiplied by the number of shares: for past years this page multiplies the diluted share count in each annual report by the closing price for the month that fiscal year ended in, and today's figure comes from the live quote.

How to read it

It is what the stock market says the whole company is worth — a measure of size, not of whether the shares are cheap or dear.

More on GALT

Galectin Therapeutics Inc., figure by figure

Galectin Therapeutics Inc. (GALT) overview: price, valuation and scorecard

Galectin Therapeutics Inc. market cap: questions and answers

What is Galectin Therapeutics Inc.'s market cap?

Galectin Therapeutics Inc. (GALT) has a market cap of $293.47M. At the end of fiscal 2025 (December 31, 2025) its market cap was $265.84M. That is 230.7% higher than the $80.38M of fiscal 2024.

What is the growth rate of Galectin Therapeutics Inc.'s market cap?

Over the five fiscal years to 2025 the market cap grew at a compound 15.8% a year.

What are the highest and lowest market cap figures on record for Galectin Therapeutics Inc.?

Across the 6 fiscal year-ends on record (2020–2025), the highest was $265.84M in fiscal 2025 and the lowest $67.11M in fiscal 2022.

How is Galectin Therapeutics Inc.'s market cap calculated?

Market cap is the share price multiplied by the number of shares: for past years this page multiplies the diluted share count in each annual report by the closing price for the month that fiscal year ended in, and today's figure comes from the live quote. For Galectin Therapeutics Inc. it is on record here for 6 fiscal years, 2020 to 2025.

Share prices are Yahoo Finance's monthly closes: a fiscal year-end is paired with the close of the month it falls in, and today's quote may be delayed. Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Galectin Therapeutics Inc. (GALT) market cap”, data as of 18 November 2026. https://funkfolio.com/stock/GALT/market-cap

Underlying data: the company's filings with the SEC and Yahoo Finance.